Jasper Therapeutics Inc - Warrants (24/09/2026)
JSPRW
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.42M
Close$
$1.79
13363.2% upside
Current Fair Value
13363.2% upsideUndervalued by 13363.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $9.42 Million |
|---|---|
| Enterprise Value | $-3,968,636.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.95 |
| Beta | 3.07 |
| Outstanding Shares | 19,168,110 |
Return
| Return on Equity | -818.74% |
|---|---|
| Return on Assets | -131.41% |
| Return on Invested Capital | -601.34% |
Valuation & Multiples
| P/E Ratio | -0.17 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.05 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.19 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.49
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 7, 2026
EPS Estimate
$-0.28
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jasper Therapeutics Inc
3 employees